Madeline Choi
Vorstandsvorsitzender bei DNAGO.Ai
Vermögen: 1 Mio $ am 31.05.2024
Profil
Madeline Choi is currently the Chief Executive Officer at DNAGO.Ai.
Prior to this, she worked as a Secretary at Hi-Great Group Holding Co. from 2020 to 2022.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.12.2022 | 1 000 000 ( 1,06% ) | 1 Mio $ | 31.05.2024 |
Aktive Positionen von Madeline Choi
| Unternehmen | Position | Beginn |
|---|---|---|
DNAGO.Ai
 DNAGO.Ai Medical/Nursing ServicesHealth Services Part of Oncologix Tech, Inc., DNAGO.Ai is a company that specializes in cell banking technology, specifically in dermal papilla cells. The company is based in Irvine, CA. The company also conducts research in other areas and have a research institute. The CEO of the company is Madeline Choi. DNAGO.Ai was acquired by Oncologix Tech, Inc. on June 30, 2022. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Madeline Choi
| Unternehmen | Position | Ende |
|---|---|---|
| HI-GREAT GROUP HOLDING COMPANY | Unternehmenssekretär | 22.09.2022 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HI-GREAT GROUP HOLDING COMPANY | Distribution Services |
| Private Unternehmen | 1 |
|---|---|
DNAGO.Ai
DNAGO.Ai Medical/Nursing ServicesHealth Services Part of Oncologix Tech, Inc., DNAGO.Ai is a company that specializes in cell banking technology, specifically in dermal papilla cells. The company is based in Irvine, CA. The company also conducts research in other areas and have a research institute. The CEO of the company is Madeline Choi. DNAGO.Ai was acquired by Oncologix Tech, Inc. on June 30, 2022. | Health Services |
